MARCAINA Side Effects

6316124-8 | Hypoaesthesia, Motor Dysfunction, Sensory Loss
on Aug 12, 2009 Male patient from BRAZIL , 48 years of age, was diagnosed with spinal anaesthesia and was treated with Marcaina (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia, motor dysfunction, sensory loss. Marcaina dosage: .

4577614-1 | Anaesthetic Complication, Eyelid Ptosis, Mydriasis, Optic Nerve Disorder, Orbital Oedema
Patient was taking Marcaina (View Usage). Patient had the following side effects: anaesthetic complication, eyelid ptosis, mydriasis, optic nerve disorder, orbital oedema on Jan 25, 2005 from Additional patient health information: Female patient , 70 years of age, was diagnosed with local anaesthesia and. Marcaina dosage: 6.67 Mg Once Pneu. During the same period patient was treated with LIDOCAINE HCL (1 Mg Once Pneu) (View Lidocaine Hcl Review and Lidocaine Hcl Label ), HYALURONIDASE (2 Ml Once Pneu) (View Hyaluronidase Review and Hyaluronidase Label ), CONCENTRATED ELECTROLYTIC SOLUTION (1 Ml Once Pneu) (View Concentrated Electrolytic Solution Review and Concentrated Electrolytic Solution Label ).

4577613-X | Anaesthetic Complication, Eyelid Ptosis, Mydriasis, Optic Nerve Disorder, Orbital Oedema
Adverse event was reported on Jan 25, 2005 by a Female patient taking Marcaina (View Usage) (Dosage: 6.67 Mg Once Pneu) was diagnosed with local anaesthesia and. Location: , 72 years of age, After Marcaina was administered, patient had the following side effects: anaesthetic complication, eyelid ptosis, mydriasis, optic nerve disorder, orbital oedema. During the same period patient was treated with LIDOCAINE HCL (1 Mg Once Pneu) (View Lidocaine Hcl Review and Lidocaine Hcl Label ), HYALURONIDASE (2 Ml Once Pneu) (View Hyaluronidase Review and Hyaluronidase Label ), CONCENTRATED ELECTROLYTIC SOLUTION (1 Ml Once Pneu) (View Concentrated Electrolytic Solution Review and Concentrated Electrolytic Solution Label ).

4577612-8 | Anaesthetic Complication, Eyelid Ptosis, Mydriasis, Optic Nerve Disorder, Orbital Oedema, Pallor
on Jan 25, 2005 Female patient from , 74 years of age, was diagnosed with local anaesthesia and was treated with Marcaina (View Usage). Patient experienced the following unwanted or unexpected effects: anaesthetic complication, eyelid ptosis, mydriasis, optic nerve disorder, orbital oedema, pallor. Marcaina dosage: 6.67 Mg Once Pneu. During the same period patient was treated with LIDOCAINE HCL (1 Mg Once Pneu) (View Lidocaine Hcl Review and Lidocaine Hcl Label ), HYALURONIDASE (2 Ml Once Pneu) (View Hyaluronidase Review and Hyaluronidase Label ), CONCENTRATED ELECTROLYTIC SOLUTION (1 Ml Once Pneu) (View Concentrated Electrolytic Solution Review and Concentrated Electrolytic Solution Label ).


4577575-5 | Anaesthetic Complication, Eyelid Ptosis, Mydriasis, Optic Atrophy, Orbital Oedema
on Jan 25, 2005 Male patient from , 68 years of age, was diagnosed with local anaesthesia and was treated with Marcaina (View Usage). Patient had the following side effects: anaesthetic complication, eyelid ptosis, mydriasis, optic atrophy, orbital oedema. Marcaina dosage: 6.67 Mg Once Pneu. During the same period patient was treated with LIDOCAINE HCL (1 Mg Once Pneu) (View Lidocaine Hcl Review and Lidocaine Hcl Label ), HYALURONIDASE (2 Ml Once Pneu) (View Hyaluronidase Review and Hyaluronidase Label ), CONCENTRATED ELECTROLYTIC SOLUTION (1 Ml Once Pneu) (View Concentrated Electrolytic Solution Review and Concentrated Electrolytic Solution Label ).

4577571-8 | Anaesthetic Complication, Eyelid Ptosis, Mydriasis, Optic Atrophy, Orbital Oedema
Patient was taking Marcaina (View Usage). After Marcaina was administered, patient had the following side effects: anaesthetic complication, eyelid ptosis, mydriasis, optic atrophy, orbital oedema on Jan 25, 2005 from Additional patient health information: Male patient , 65 years of age, was diagnosed with local anaesthesia and. Marcaina dosage: 6.67 Mg Once Pneu. During the same period patient was treated with LIDOCAINE HCL (1 Mg Once Pneu) (View Lidocaine Hcl Review and Lidocaine Hcl Label ), HYALURONIDASE (2 Ml Once Pneu) (View Hyaluronidase Review and Hyaluronidase Label ), CONCENTRATED ELECTROLYTIC SOLUTION (1 Ml Once Pneu) (View Concentrated Electrolytic Solution Review and Concentrated Electrolytic Solution Label ).

4577570-6 | Anaesthetic Complication, Eyelid Ptosis, Mydriasis, Optic Atrophy, Orbital Oedema
Adverse event was reported on Jan 25, 2005 by a Male patient taking Marcaina (View Usage) (Dosage: 6.67 Mg Once Pneu) was diagnosed with local anaesthesia and. Location: , 74 years of age, Patient experienced the following unwanted or unexpected effects: anaesthetic complication, eyelid ptosis, mydriasis, optic atrophy, orbital oedema. During the same period patient was treated with LIDOCAINE HCL (1 Mg Once Pneu) (View Lidocaine Hcl Review and Lidocaine Hcl Label ), HYALURONIDASE (2 Ml Once Pneu) (View Hyaluronidase Review and Hyaluronidase Label ), CONCENTRATED ELECTROLYTIC SOLUTION (1 Ml One Pneu) (View Concentrated Electrolytic Solution Review and Concentrated Electrolytic Solution Label ).

4577565-2 | Anaesthetic Complication, Eyelid Ptosis, Mydriasis, Optic Atrophy, Orbital Oedema
on Jan 25, 2005 Male patient from , 55 years of age, was diagnosed with local anaesthesia and was treated with Marcaina (View Usage). Patient had the following side effects: anaesthetic complication, eyelid ptosis, mydriasis, optic atrophy, orbital oedema. Marcaina dosage: 6.67 Mg Once Pneu. During the same period patient was treated with LIDOCAINE (1 Mg Once Pneu) (View Lidocaine Review and Lidocaine Label ), CONCENTRATED ELECTROLYTE SOLUTION (1 Ml One Pneu) (View Concentrated Electrolyte Solution Review and Concentrated Electrolyte Solution Label ), HYALURONIDASE (2 Ml Once Pneu) (View Hyaluronidase Review and Hyaluronidase Label ).